What is Hapbee?
Founded in 2019, Hapbee operates at the vanguard of wearable technology, specializing in the development of devices that utilize patented ulRFE technology. The company's core value proposition lies in its ability to deliver low-power electromagnetic signals that influence user states, ranging from focus and alertness to relaxation. By digitizing the sensations of various compounds and states, Hapbee provides a non-invasive alternative for individuals seeking to manage their daily well-being through advanced bio-hacking tools.
The company's market position is defined by its unique intellectual property and its direct-to-consumer distribution model via Hapbee.com. As the wellness industry shifts toward data-driven and personalized health solutions, Hapbee's ability to provide tangible, on-demand physiological shifts places it in a distinct category, separate from traditional wearable fitness trackers that primarily focus on biometric monitoring rather than active state modulation.
How much funding has Hapbee raised?
Hapbee has raised a total of $15M across 5 funding rounds:
Share Placement
$8M
Share Placement
$1.1M
Share Placement
$2.8M
Share Placement
$2M
Stock/Share Issuance
$1.1M
Share Placement (2022): $8M, investors not publicly disclosed
Share Placement (2022): $1.1M, investors not publicly disclosed
Share Placement (2024): $2.8M, investors not publicly disclosed
Share Placement (2024): $2M, investors not publicly disclosed
Stock/Share Issuance (2025): $1.1M, investors not publicly disclosed
Key Investors in Hapbee
Hapbee
Undisclosed investor participating in the funding round.
Hapbee
Undisclosed investor participating in the funding round.
Hapbee
Undisclosed investor participating in the funding round.
What's next for Hapbee?
With the recent influx of capital, Hapbee is well-positioned to accelerate its research and development initiatives, potentially expanding its library of digital signals and enhancing the hardware form factor. The strategic focus will likely shift toward broader market penetration and the integration of its technology into broader enterprise wellness ecosystems. As the company matures, the emphasis will remain on clinical validation and scaling production to meet the rising demand for sophisticated, non-pharmacological wellness interventions.
Future growth will be contingent upon the firm's ability to maintain its technological edge while navigating the regulatory landscape governing wearable health devices. By continuing to secure strategic financing, Hapbee is effectively building the infrastructure necessary to transition from a niche innovator to a mainstream player in the global health and wellness technology market.
